Cargando…

Assessing health-related quality of life in urology – a survey of 4500 German urologists

BACKGROUND: Urological diseases and their treatment may negatively influence continence, potency, and health-related quality of life (HRQOL). Although current guidelines recommend HRQOL assessment in clinical urology, specific guidance on how to assess HRQOL is frequently absent. We evaluated whethe...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmick, A., Juergensen, M., Rohde, V., Katalinic, A., Waldmann, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477301/
https://www.ncbi.nlm.nih.gov/pubmed/28629351
http://dx.doi.org/10.1186/s12894-017-0235-1
_version_ 1783244764503605248
author Schmick, A.
Juergensen, M.
Rohde, V.
Katalinic, A.
Waldmann, A.
author_facet Schmick, A.
Juergensen, M.
Rohde, V.
Katalinic, A.
Waldmann, A.
author_sort Schmick, A.
collection PubMed
description BACKGROUND: Urological diseases and their treatment may negatively influence continence, potency, and health-related quality of life (HRQOL). Although current guidelines recommend HRQOL assessment in clinical urology, specific guidance on how to assess HRQOL is frequently absent. We evaluated whether and how urologists assess HRQOL and how they determine its practicality. METHODS: A random sample of 4500 (from 5200 identified German urologists) was drawn and invited to participate in a postal survey (an initial letter followed by one reminder after six weeks). The questionnaire included questions on whether and how HRQOL is assessed, general attitudes towards the concept of HRQOL, and socio-demographics. Due to the exploratory character of the study we produced mainly descriptive statistics. Chi(2)-tests and logistic regression were used for subgroup-analysis. RESULTS: 1557 urologists (85% male, with a mean age of 49 yrs.) participated. Most of them (87%) considered HRQOL assessment as ‘important’ in daily work, while only 7% reported not assessing HRQOL. Patients with prostate carcinoma, incontinence, pain, and benign prostate hyperplasia were the main target groups for HRQOL assessment. The primary aim of HRQOL assessment was to support treatment decisions, monitor patients, and produce a ‘baseline measurement’. Two-thirds of urologists used questionnaires and interviews to evaluate HRQOL and one-quarter assessed HRQOL by asking: ‘How are you?’. The main barriers to HRQOL assessment were anticipated questionnaire costs (77%), extensive questionnaire length (52%), and complex analysis (51%). CONCLUSIONS: The majority of German urologists assess HRQOL as part of their clinical routine. However, knowledge of HRQOL assessment, analysis, and interpretation seems to be limited in this group. Therefore, urologists may benefit from a targeted education program. TRIAL REGISTRATION: The clinical trial was registered with the code VfD_13_003629 at the German Healthcare Research Registry (www.versorgungsforschung-deutschland.de).
format Online
Article
Text
id pubmed-5477301
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54773012017-06-23 Assessing health-related quality of life in urology – a survey of 4500 German urologists Schmick, A. Juergensen, M. Rohde, V. Katalinic, A. Waldmann, A. BMC Urol Research Article BACKGROUND: Urological diseases and their treatment may negatively influence continence, potency, and health-related quality of life (HRQOL). Although current guidelines recommend HRQOL assessment in clinical urology, specific guidance on how to assess HRQOL is frequently absent. We evaluated whether and how urologists assess HRQOL and how they determine its practicality. METHODS: A random sample of 4500 (from 5200 identified German urologists) was drawn and invited to participate in a postal survey (an initial letter followed by one reminder after six weeks). The questionnaire included questions on whether and how HRQOL is assessed, general attitudes towards the concept of HRQOL, and socio-demographics. Due to the exploratory character of the study we produced mainly descriptive statistics. Chi(2)-tests and logistic regression were used for subgroup-analysis. RESULTS: 1557 urologists (85% male, with a mean age of 49 yrs.) participated. Most of them (87%) considered HRQOL assessment as ‘important’ in daily work, while only 7% reported not assessing HRQOL. Patients with prostate carcinoma, incontinence, pain, and benign prostate hyperplasia were the main target groups for HRQOL assessment. The primary aim of HRQOL assessment was to support treatment decisions, monitor patients, and produce a ‘baseline measurement’. Two-thirds of urologists used questionnaires and interviews to evaluate HRQOL and one-quarter assessed HRQOL by asking: ‘How are you?’. The main barriers to HRQOL assessment were anticipated questionnaire costs (77%), extensive questionnaire length (52%), and complex analysis (51%). CONCLUSIONS: The majority of German urologists assess HRQOL as part of their clinical routine. However, knowledge of HRQOL assessment, analysis, and interpretation seems to be limited in this group. Therefore, urologists may benefit from a targeted education program. TRIAL REGISTRATION: The clinical trial was registered with the code VfD_13_003629 at the German Healthcare Research Registry (www.versorgungsforschung-deutschland.de). BioMed Central 2017-06-19 /pmc/articles/PMC5477301/ /pubmed/28629351 http://dx.doi.org/10.1186/s12894-017-0235-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Schmick, A.
Juergensen, M.
Rohde, V.
Katalinic, A.
Waldmann, A.
Assessing health-related quality of life in urology – a survey of 4500 German urologists
title Assessing health-related quality of life in urology – a survey of 4500 German urologists
title_full Assessing health-related quality of life in urology – a survey of 4500 German urologists
title_fullStr Assessing health-related quality of life in urology – a survey of 4500 German urologists
title_full_unstemmed Assessing health-related quality of life in urology – a survey of 4500 German urologists
title_short Assessing health-related quality of life in urology – a survey of 4500 German urologists
title_sort assessing health-related quality of life in urology – a survey of 4500 german urologists
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477301/
https://www.ncbi.nlm.nih.gov/pubmed/28629351
http://dx.doi.org/10.1186/s12894-017-0235-1
work_keys_str_mv AT schmicka assessinghealthrelatedqualityoflifeinurologyasurveyof4500germanurologists
AT juergensenm assessinghealthrelatedqualityoflifeinurologyasurveyof4500germanurologists
AT rohdev assessinghealthrelatedqualityoflifeinurologyasurveyof4500germanurologists
AT katalinica assessinghealthrelatedqualityoflifeinurologyasurveyof4500germanurologists
AT waldmanna assessinghealthrelatedqualityoflifeinurologyasurveyof4500germanurologists